|

TLN-121 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Treeline Biosciences, Inc.1

Indications

  • Lymphoma, Non-Hodgkin1
  • Lymphoma1
  • Cancer1

Palo Alto, California1 trial

TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas

Stanford Medicine Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.